Endostapler Hemostasis Study
- Conditions
- Intraoperative Staple Line Bleeding as Measured by the Provided Bleeding Severity Scale
- Interventions
- Device: AEON EndostaplerDevice: Echelon Flex Powered Stapler
- Registration Number
- NCT04149925
- Lead Sponsor
- Lexington Medical Inc.
- Brief Summary
The goal of this prospective, multi-center, post-market study is to measure AEON™ Endostapler performance with the EASY/THICK MODE feature for laparoscopic bariatric surgery against the Echelon Flex™ Powered Stapler system from Ethicon. Stapler performance will be evaluated primarily by incidence and degree of staple line bleeding through a third-party blinded primary outcome evaluator. The study will include 60 total consecutive cases of individuals undergoing a planned laparoscopic sleeve gastrectomy (LSG). The LSG procedure will be performed according to institutional standard-of-care and all subjects will undergo standard preoperative evaluation as well as post-operative care. Relevant data will be collected using the Data Collection sheet which should be filled out following each procedure by a member of the surgical or nursing team.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Patients undergoing planned laparoscopic sleeve gastrectomy with signed surgery consent form
- Informed consent for study obtained and signed from each subject
- Planned open surgical approach
- Prior bariatric operation (i.e. revisional bariatric surgery)
- Use of staple line reinforcement material (buttress)
- Patients taking anticoagulants
- Patients under the age of 18 on the date of the surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description AEON Endostapler AEON Endostapler Stapling performed by AEON Endostapler Echelon Flex Powered Stapler Echelon Flex Powered Stapler Stapling performed by Echelon Flex Powered Stapler
- Primary Outcome Measures
Name Time Method Staple Line Bleeding 10 seconds after last staple line Intraoperative staple line bleeding as measured by the provided bleeding severity scale (1: No bleeding; 2: Minimal bleeding; 3: Moderate bleeding; 4: Excessive bleeding; 5: Profuse bleeding)
- Secondary Outcome Measures
Name Time Method Product Malfunction During surgery Incidence of product malfunction during procedure
Staple Line Leaking 1 month following procedure Incidence of postoperative leakage during one-month monitoring period following procedure
Blood Transfusion Within 72 hours of surgery start Incidence of intraoperative or postoperative blood transfusion within 72 hours of surgery start time
Pain Level 1 week following procedure Postoperative pain level as measured by a standard pain severity scale of 0-10 where 0 means no pain and 10 means severe pain.
Adverse Events 1 month following procedure Incidence of reported device-related adverse events
Trial Locations
- Locations (3)
Avala Hospital
🇺🇸Covington, Louisiana, United States
Crescent City Surgical Centre
🇺🇸Metairie, Louisiana, United States
Southern Surgical Hospital
🇺🇸Slidell, Louisiana, United States